Press Release
Nov 15, 2022
Contact: Chris Martin, IASLC Media Relations, cmartin@davidjamesgroup.com, 630.670.2745
(Denver, CO November 14, 2022) – The International Association for the Study of Lung Cancer today named four highly regarded thoracic oncologists Narjust Florez, MD; Linda Martin, MD; Fabio Ynoe de Moraes, MD, Ph.D., MBA; and Sandip Patel, MD; as co-chairs of the IASLC 2024 World Conference on Lung Cancer.
Co-chairs work with the IASLC to plan the annual meeting, select program track members and meeting content, and serve as ambassadors for international oncologists who attend the meeting.
Narjust Florez, MD, is the associate director of the Cancer Care Equity Program, a thoracic medical oncologist at the Dana-Farber Cancer Institute/Harvard Cancer Center, and an assistant professor of Medicine at Harvard Medical School. In 2022, Dr. Florez also became the first Latina to hold an associate editor position in oncology as the new associate editor for Diversity, Equity, and Inclusion at the JAMA Oncology Journal. She is the co-founder of the #LatinasInMedicine online community and the Florez Laboratory. Additionally, Dr. Florez is one of the co-hosts for Lung Cancer Considered, the official IASLC podcast, is a member of the LATAM Working Group, and is active with the IASLC’s Women in Thoracic Oncology Group
Linda Martin, MD, is chief of Thoracic Surgery at the University of Virginia, where she holds the rank of tenured associate professor of surgery. She is vice-chair of the Respiratory Committee for Alliance and serves as an investigator in several clinical trials for multidisciplinary care of thoracic cancers. She is the Society of Thoracic Surgeons representative to the American College of Surgeons Commission on Cancer and is involved in multiple leadership roles to develop and implement cancer surgery standards. She is internationally recognized for her work on enhanced recovery in thoracic surgery, reducing opioid use, and speeding recovery of patients after lung cancer resection. Dr. Martin has served as invited faculty for the NACLC and has been an IASLC member since 2017.
Fabio Ynoe de Moraes, MD, Ph.D., MBA, is an associate professor and principal investigator at Queen’s University, Kingston, Ontario, Canada, and a radiation oncologist focusing on exploring the intersection between health policy, innovation, and thoracic oncology, as well as a principal investigator in health services research and AI. Dr. Moraes is an active member of the IASLC as invited faculty for WCLC 2020, and two-time IASLC Academy Award Winner.
Sandip Patel, MD, is a professor at the University of California San Diego and a medical oncologist focusing on early-phase clinical trials of immunotherapy and thoracic oncology. He is an active member of IASLC and serves on the Communications and Career Development & Fellowship Committees and was invited faculty at the 2020 TTLC Meeting. Dr. Patel is the leader for the Experimental Therapeutics (Phase 1) Program and deputy director for the Center for Precision Immunotherapy at UCSD. He is the director of the Clinical Trials Office at UCSD Moores Cancer Center. He is co-leader of the NRG Developmental Therapeutics Committee and co-leader of the University of California Lung Cancer Consortium.
###
About the IASLC
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.
